Faron Pharmaceuticals Ltd., Turku PET Centre deal

Faron and the Turku PET Centre partnered to develop Faron’s Clevegen, a preclinical immunotherapeutic for cancer. The center will use its PET imaging to explore the use of Clevegen in treating cancer...